Clinical Trial Update: Tolerability and Pharmacokinetics of M2ES in the Treatment of Advanced Solid Tumor [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update reports tolerability and pharmacokinetics of M2ES in patients with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Endostatin (endostatin)
• M2ES

Snippet

Sponsor: Sun Yat-sen University | Conditions: Tolerability, Pharmacokinetics | Phase 1 | Status: COMPLETED